Insilico Medicine vs Recursion

TL;DR:

Insilico Medicine emphasizes computational generative AI models (including large language models) that span the entire drug discovery workflow with validated clinical programs, while Recursion focuses on generating and analyzing massive proprietary experimental datasets through high-throughput automated wet labs and phenomics. The key difference is approach: Insilico leads with AI-first computational chemistry/biology and offers API access, whereas Recursion generates biological insights from unprecedented scale of actual laboratory experimentation powered by their supercomputer. Both target enterprise customers but Recursion's competitive advantage lies in its unique physical infrastructure and proprietary data moat.